Management Team
CSO & Senior VP, Early Discovery
Dr. Gu brings over 15 years of industry experience in cancer research and drug discovery. Before joining Curon, Dr. Gu was the VP of Qilu (Shanghai) Innovation center, prior to that, he acted as the head of Biologics development at Abpro Labs at Boston, and Executive Director of Biologics Discovery at Shanghai Hengrui Pharmaceutical. Dr Gu started his career at Abbott/Abbvie. He received his PhD degree in molecular biology at Vanderbilt University.
Jinming Gu, PhD
Dr. Li brings 13 years’ experience of medical practice, and about 10 years biomedical research and drug discovery experience in immune-oncology and infectious diseases. Prior to Curon, she worked as physician scientist on immune-oncology and translational research at Agios Pharmaceuticals and Constellation Pharmaceuticals at Boston.
Dr. Li graduated from Hebei Medical University, finished her resident internship at the 4th affiliated hospital, HMU. Dr. Li practiced medicine as associate chief physician at Beijing You’an hospital for 13 years. She obtained her PhD degree from Capital Medical University and received Postdoc training at Harvard Medical School.
Executive Medical Director，Clinical Development
Haiying Li, MD, PhD
